Prognostic Impact of Lesion-specific Hemodynamic Index in Patients With Coronary Artery Disease (PRIME-FFR)

Seoul National University

Status: Enrolling

Conditions: Coronary Artery Disease

Treatments: Diagnostic Test: Fractional flow reserve

Study type: Observational

Funder types: Other

Identifiers

NCT05250557

H-2107-230-1240

Details and patient eligibility

About

The investigators aim to investigate the additive prognostic value of lesion-specific hemodynamic index such as ΔFFR, non-hyperemic pressure ratio such as RFR, over % diameter stenosis and FFR according to treatment strategy, and to find the prognostic implications of post-PCI FFR after adjustment of various clinical and disease characteristics, and to construct a comprehensive risk prediction model for post-PCI outcomes.

Full description

Fractional flow reserve (FFR)-based revascularization is the currently best practice recommended by guidelines. In addition to the use of coronary physiological indices as a vessel-specific metric, recent studies suggested the clinical importance of local hemodynamics in prediction of risk for target vessel failure or acute coronary syndrome in patients with coronary artery disease. In patients who receive percutaneous coronary intervention (PCI), the absolute value and pattern of FFR change after stenting are helpful in defining the additional target for PCI and risk stratification after PCI. However, there has been no prospective study that proved the benefit of change in FFR across the lesion (ΔFFR) in daily clinical practice, and FFR usage after stenting is much less than before stenting. Accordingly, we will prove the benefit of ΔFFR in addition to FFR, prognostic implications of combining RFR and FFR, and the comprehensive risk model with post-PCI FFR, clinical and disease characteristics in a prospective study, to maximize the benefit of invasive physiologic assessment.

Enrollment: 2,429 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥20 years
2. All comers who underwent successful FFR measurement and pullback tracing

Exclusion criteria

1. Chronic renal failure (estimated glomerular filtration rate <30)
2. ST-elevation myocardial infarction within 72 hours or previous coronary artery bypass graft surgery history
3. Primary myocardial or valvular disease
4. Left ventricular ejection fraction < 30%
5. Hemodynamically unstable clinical conditions
6. Life expectancy < 2 years

Trial design

2,429 participants in 2 patient groups

Deferral of PCI group

Description:

Patients who undergo successful FFR pullback tracing and have a vessel determined to defer revascularization after FFR measurement will be included.

Treatment:

Diagnostic Test: Fractional flow reserve

PCI group

Description:

Patients who undergo successful FFR pullback tracing and have a vessel that undergo stent implantation and FFR measurement both before and after revascularization (pre-PCI FFR and post-PCI FFR) will be included.

Treatment:

Diagnostic Test: Fractional flow reserve